UBS(Lux)E.F.-S.Health Tr.(USD)Q CHF H
LU2402148659
UBS(Lux)E.F.-S.Health Tr.(USD)Q CHF H/ LU2402148659 /
NAV06/11/2024 |
Diferencia+0.0300 |
Tipo de beneficio |
Enfoque de la inversión |
Sociedad de fondos |
98.3500CHF |
+0.03% |
reinvestment |
Equity
Worldwide
|
UBS AM S.A. (EU) ▶ |
Estrategia de inversión
The actively managed investment fund invests worldwide primarily in equities of companies related to the healthcare sector. This sub-fund promotes environmental and/or social features but does not pursue a sustainable investment objective. Based on thorough analyses by our investment specialists, the fund manager combines carefully selected stocks of different companies from different countries and different segments of the sector with the objective of taking advantage of interesting opportunities for returns while keeping risks under control. UBS Asset Management classifies this investment fund as a Sustainability Focus Fund, which promotes environmental and/or social characteristics.
The portfolio manager has discretion to construct the portfolio and is not bound by the benchmark in terms of equities and weightings. The investment fund is actively managed relative to the benchmark MSCI World Health Care (net div. reinv.). The investment fund uses the benchmark MSCI World Health Care (net div. reinv.) for portfolio composition, performance comparison and risk management.
Objetivo de inversión
The actively managed investment fund invests worldwide primarily in equities of companies related to the healthcare sector. This sub-fund promotes environmental and/or social features but does not pursue a sustainable investment objective. Based on thorough analyses by our investment specialists, the fund manager combines carefully selected stocks of different companies from different countries and different segments of the sector with the objective of taking advantage of interesting opportunities for returns while keeping risks under control. UBS Asset Management classifies this investment fund as a Sustainability Focus Fund, which promotes environmental and/or social characteristics.
Datos maestros
Tipo de beneficio: |
reinvestment |
Categoría de fondos: |
Equity |
Región: |
Worldwide |
Sucursal: |
Sector Health / Pharma |
Punto de referencia: |
MSCI World Health Care (net div. reinv.) |
Inicio del año fiscal: |
01/12 |
Última distribución: |
- |
Banco depositario: |
UBS Europe SE, Luxembourg Branch |
País de origen: |
Luxembourg |
Permiso de distribución: |
Austria, Germany, Switzerland, Luxembourg, Czech Republic |
Gestor de fondo: |
Matthew Konosky, Scott Wilkin, Caroline Wallace |
Volumen de fondo: |
211.41 millones
USD
|
Fecha de fundación: |
24/11/2021 |
Enfoque de la inversión: |
- |
Condiciones
Recargo de emisión: |
5.00% |
Max. Comisión de administración: |
0.77% |
Inversión mínima: |
- CHF |
Deposit fees: |
- |
Cargo por amortización: |
0.00% |
Prospecto simplificado: |
Descargar (Versión para imprimir) |
Sociedad de fondos
Fondos de empresa: |
UBS AM S.A. (EU) |
Dirección: |
33A avenue J.F. Kennedy, 1855, Luxembourg |
País: |
Luxembourg |
Internet: |
www.ubs.com
|
Activos
Stocks |
|
98.59% |
Cash |
|
1.40% |
Otros |
|
0.01% |
Países
United States of America |
|
57.21% |
Switzerland |
|
14.05% |
United Kingdom |
|
9.39% |
Netherlands |
|
6.82% |
Japan |
|
4.43% |
China |
|
1.73% |
Denmark |
|
1.67% |
Cash |
|
1.40% |
Germany |
|
1.11% |
Bermuda |
|
0.99% |
Virgin Islands (British) |
|
0.83% |
Ireland |
|
0.36% |
Otros |
|
0.01% |
Sucursales
Pharma/Biotechnology |
|
50.39% |
Healthcare services |
|
26.35% |
Healthcare appliances |
|
17.97% |
grooming products |
|
1.82% |
Cash |
|
1.40% |
Gesundheitswesen/ Informationstechnologie |
|
1.18% |
Parma, wholesale |
|
0.89% |